Extrapleural pneumonectomy versus pleurectomy/decortication in malignant pleural mesothelioma: an updated meta-analysis of survival endpoints

D. Magouliotis (Larissa, Greece), V. Tasiopoulou (Larissa, Greece), K. Spiliopoulos (Larissa, Greece), K. Svokos (Providence, RI, United States of America), A. Svokos (Lewisburg, PA, United States of America), K. Athanassiadi (Athens, Greece)

Source: International Congress 2019 – All aspects of general thoracic surgery
Session: All aspects of general thoracic surgery
Session type: Oral Presentation
Number: 3787
Disease area: Respiratory infections, Thoracic oncology

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Magouliotis (Larissa, Greece), V. Tasiopoulou (Larissa, Greece), K. Spiliopoulos (Larissa, Greece), K. Svokos (Providence, RI, United States of America), A. Svokos (Lewisburg, PA, United States of America), K. Athanassiadi (Athens, Greece). Extrapleural pneumonectomy versus pleurectomy/decortication in malignant pleural mesothelioma: an updated meta-analysis of survival endpoints. 3787

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients
Source: Eur Respir J 2011; 38: 1425-1430
Year: 2011



Pleurectomy/decortication for malignant pleural mesothelioma: a single-centre experience.
Source: Virtual Congress 2020 – Thoracic surgery: developments in diagnostics and outcomes
Year: 2020


Malignant pleural mesothelioma (MPM): clinical presentation, complications and survival
Source: Eur Respir J 2002; 20: Suppl. 38, 272s
Year: 2002

Survival time in patients with malignant pleural mesothelioma
Source: Annual Congress 2007 - Rare tumours, risk factors and epidemiology in thoracic oncology
Year: 2007


Pleurectomy, decortication and hyperthermic chemotheraphy in malignant pleural mesothelioma, a single institution experience
Source: International Congress 2017 – General thoracic surgery
Year: 2017

Is there any advantage of chemotherapy on survival of patients with diffuse malignant pleural mesothelioma?
Source: Eur Respir J 2003; 22: Suppl. 45, 29s
Year: 2003

Late Breaking Abstract - Comparison of VATS debulking surgery and HITHOC vs VATS talc pleurodesis alone in malignant pleural mesothelioma: a pilot study
Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Year: 2020




Thoracoscopic evaluation of the effect of tumour burden on the outcome of pleurodesis in malignant pleural effusion
Source: Virtual Congress 2021 – Pleural disease and bronchoscopic lung volume reduction
Year: 2021


Talc pleurodesis in malignant pleural effusions: A 5-year experience
Source: Annual Congress 2012 - Medical access to the pleura
Year: 2012

Treatment of malignant pleural mesothelioma with caelyx: few responses but good survival
Source: Eur Respir J 2004; 24: Suppl. 48, 526s
Year: 2004

Role of surgery and of radiotherapy in malignant pleural mesothelioma
Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases
Year: 2020


Cisplatin/pemetrexed chemotherapy versus palliative care survival in malignant pleural mesothelioma
Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma
Year: 2018

Malignant pleural mesothelioma clinical aspects and survival in 93 cases
Source: Annual Congress 2010 - Current issues in malignant pleural diseases
Year: 2010

Possibilities of reconstruction during pleuropneumonectomy with resection of pericardium and diaphragm in patients with malignant pleural mesothelioma
Source: Eur Respir J 2006; 28: Suppl. 50, 719s
Year: 2006

Epidemiology, histology and thoracoscopic findings in malignant pleural mesothelioma (MPM) as second tumour in a single-centre cohort
Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions
Year: 2010

Impact of tumour thickness on survival after radical radiation and surgery in malignant pleural mesothelioma
Source: Eur Respir J , 49 (3) 1601428; DOI: 10.1183/13993003.01428-2016
Year: 2017




Malignant pleural mesothelioma: our multimodality approach
Source: Eur Respir J 2002; 20: Suppl. 38, 40s
Year: 2002

Malignant pleural mesothelioma: new treatment modalities
Source: Annual Congress 2005 - Clinical year in review
Year: 2005

Chemotherapy for treatment of malignant pleural mesothelioma
Source: Eur Respir J 2004; 24: Suppl. 48, 526s
Year: 2004

Drain site radiotherapy in malignant pleural mesothelioma: a wasted resource
Source: Eur Respir J 2007; 30: 1021
Year: 2007